Huwebes, Nobyembre 24, 2011

Dr. Lindsay Rosenwald: Combining years of experience in OpusPoint

Investing in innovation is how OpusPoint Partners describes its business. Founded in 2009 by Michael S. Weiss and Dr. Lindsay Rosenwald, the company was formed, in the founders’ own words, to “raise the bar for investing and advising emerging companies.” Focusing mainly on biotechnology, OpusPoint Partners strives to uphold a strong sense of integrity as it upholds its commitment to help the medical and healthcare industry grow through investments.

Dr. Lindsay Rosenwald Photo credit: Askmen

Having seen many opportunities for advancement in biotechnology, the company’s founders have pooled over their 40 years of collective experience in the field. Both founding members have established or managed companies prior to OpusPoint, many of which have flourished or have been acquired by larger pharmaceutical companies.


In the 1980s, a young Dr. Lindsay Rosenwald entered Wall Street. After his Wall Street stint, he started founding companies. Among the companies he has founded are Cougar Biotechnology, Inc. which was acquired by Johnson and Johnson. Also, between 1994 and 2007, he also ran the Aries Fund, a company dedicated to healthcare investments, and the Orion Fund which focused on private investments in biotechnology.

Dr. Lindsay Rosenwald Photo credit: Biotechnolgy-info.blogspot.com

Joining him is Michael S. Weiss, who had worked with him in the Aries Fund. In 1999, he founded Access Oncology which was later on acquired by Keryx Biopharmaceuticals in 2004. He remained as CEO of Keryx after the merger, where he helped grow the company to a $1 billion capitalization company at its peak.

From Lindsay Rosenwald

More information on the careers of Dr. Lindsay Rosenwald and his partner are available in the OpusPoint official website.

Linggo, Nobyembre 6, 2011

Dr. Lindsay Rosenwald: Playing a big role in the search for a cure for cancer

Over the course of Dr. Lindsay Rosenwald’s career, he has continually andstrongly helped in improving the state of the healthcare industry. He does this through investing on biotechnology firms and laboratories that conduct innovative researches to discover new medicines and treatments to cure various diseases.



From Dr. Lindsay Rosenwald



One exceptional accomplishment he has done in his career as a biotechnology investor is the foundation of Cougar Biotechnology, Inc., a Los Angeles-based company which conducts research on drugs for cancer. The said laboratory developed numerous drugs that made both researchers and investors excited. Cougar Biotechalso aided in the development of new drugs such as Abiraterone.



The development of Abiraterone is considered as one of Cougar Biotechand Dr. Lindsay Rosenwald’s most prized achievements. This is because scientists believe, from both preclinical and clinical studies, that this drug can help treat late-stage prostate cancer. Abiraterone has marvelously demonstrated the capability to selectively constrain target enzymes to inhibit production of testosterone in both the adrenals and the testes. This in turn may lessen the chances of the growth of prostate cancer cells.



Dr. Lindsay Rosenwald Photo Credit: http://Biotechnolgy-info.blogspot.com



Because of the success and recognition that Cougar Biotech received through its innovative products on cancer treatment, Johnson & Johnson tended to buy the company for around one billion dollars. With the resources from the bigger company, Cougar Biotech was able to continue its pioneering researches to ease the pains caused by cancer.



Like Cougar Biotech, Dr. Lindsay Rosenwald continues to create and re-capitalize private and public companies within the biotechnology sector and the life-sciences field to create a better future for mankind.



Dr. Lindsay Rosenwald Photo Credit: http://thegeminigeek.com



More information about Dr. Lindsay Rosenwald is available at www.drlindsayrosenwald.com.

Huwebes, Oktubre 27, 2011

Dr. Lindsay Rosenwald: Creating innovative cures through biotechnology

Lindsay Rosenwald Photo Credit: http://thegeminigeek.com




One of the primary goals of the medical industry is the perpetual advancement of health care. At the helm of the biotechnology arena is Dr. Lindsay Rosenwald, co-founder of the prestigious OpusPoint Partners, LLC.




In 1977, Dr. Rosenwald completed his Bachelor of Science in Finance Economics from the Pennsylvania State University. Working as an independent management consultant for health care firms developed Dr. Rosenwald’s interest in bioresearch and biotechnology. This stirred him to pursue and finish his M.D. at the Temple University School of Medicine in 1983.




Dr. Rosenwald had practiced medicine until he decided to move to New York, where he served both as a physician and a financial analyst for some of the most distinguished firms in Wall Street. Having risen through the ranks, he ventured back to the field of bioresearch and biotechnology in 1992.



Lindsay Rosenwald Photo credit: PAControl.com


Dedicating his expertise to advancing the field of biotechnology and life sciences, Dr. Lindsay Rosenwald has established and aided nearly 50 biotech firms to reach success. Included among these is Cougar Biotechnology, where Dr. Rosenwald and his team developed the acclaimed life prolonging cancer treatment known as the Abiraterone acetate. Dr. Rosenwald is also credited for having spawned a wide array of potent cures for some of the deadliest diseases including fibromyalgia, rheumatoid arthritis, and H1N1.




Together with the former CEO of Keryx Biopharmaceuticals, Inc., Michael S. Weiss, Dr. Rosenwald established the OpusPoint Partners, LLC, a distinguished health care and life sciences investment and consulting firm in the United States.




From Lindsay Rosenwald

More information about Dr. Lindsay Rosenwald and the OpusPoint Partners, LLC can be found at www.lindsayrosenwald.com.

Miyerkules, Oktubre 26, 2011

The unbreakable vow: Dr. Lindsay Rosenwald on drug development ethics

Life is never just black and white. As is often the case, life exists in multiple shades of grey. Dr. Lindsay Rosenwald and other experts in the drug development and investment industry have seen countless examples of these grey areas, such as firms that manipulate the outcome of clinical trials and physicians who have set aside their oaths for more profit.
From September 22, 2011
The Hippocratic Oath is very clear on its stand about clinical trials and research. Every physician has vowed that "Research must have as its purpose the furtherance of the health of that individual… [and he or she] will go for the benefit of the sick and will abstain from every voluntary act of mischief or corruption." Despite this, some individuals who are looking for personal gain would influence the results to coax more investors and make profit, instead of releasing true results that may impact the lives of millions.
From Biotech
Dr. Lindsay Rosenwald is a firm believer of fair play and integrity. As the co-founder of OpusPoint Partners, he leads the company in resisting temptation to manipulate the results of clinical trials and sets an example in conforming to the ethical rules and considerations of drug development. Under his leadership, the firm combines its renowned formula of integrity and applies the best practices in the industry to be among the most respected and recognized firms in finance and drug research.
From August 11, 2011
After all, the results of a clinical study could be the determining factor in a disease's eradication. Failure to provide the right results could just make patients suffer further.
Additional information about Dr. Rosenwald is available at opuspointpartners.com.

Miyerkules, Setyembre 14, 2011

Dr. Lindsay Rosenwald and biotechnology: The future of medicine

From August 11, 2011
From August 11, 2011

Advancements in technologies have benefitted many industries including the field of medicine. Moreover, scientists and medical practitioners such as Dr. Lindsay Rosenwald exploit their knowledge and skills to take science to newer heights.

Next to information technology, biotechnology and life sciences will produce broader and newer waves of opportunities that will promote many industries. However, such developments rely upon the proper collection, dissemination, and utilization of new data and technologies.

Since the dawn of the 19th century, the world has witnessed the advent of cunning devices as well as the advancement of Chemistry – all of which have helped revolutionize existing knowledge and practices in medicine. In addition, innovations in techniques and apparatuses during the past two decades not only improved the diagnosis of ailments but also contributed to the accurate treatment of a variety of diseases.

Dr. Lindsay Rosenwald, a distinguished expert in biotechnology, introduced remarkable contributions which prove to be potent cures or life-prolonging treatments for patients suffering from cancer, schizophrenia, fibromyalgia, rheumatoid arthritis, and H1N1.

In her article entitled 20 New Biotech Breakthroughs that Will Change Medicine, Melinda Wenner discusses how biotechnology will generate cutting-edge devices sure to "blur the line between biology and technology." Such inventions include decay-fighting microbes, asthma sensor, cancer spit test, biological pacemaker, smart contact lens, speech restorer, muscle stimulator, nerve regenerator, gastrointestinal liner, and a rocket-powered arm.

More information on Dr. Lindsay Rosenwald’s professional career and his contributions to the field of biotechnology can be found at DoctorLindsayRosenwald.com.
From September 22, 2011

Martes, Setyembre 6, 2011

Dr. Lindsay Rosenwald raises the bar in biotechnology investments

Dr. Lindsay Rosenwald is a renowned name in the field of biotechnology. After finishing his degree in Medicine at Temple University, Dr. Rosenwald began building his reputation in biotechnology and has contributed to the field’s development.


Dr. Lindsay RosenwaldPhoto credit: PAControl.com


Dr. Rosenwald’s knowledge and dedication in the field enables him to build companies that specialize in the development of biotechnology. One of his most recent contributions is OpusPoint Partners which was built to provide better services to the healthcare industry.


OpusPoint Partners was established in 2009 to raise the bar in biotechnology investments. Dr. Rosenwald, together with Michael S. Weiss, formed the company not only for business profits, but more on to set new standards in doing business.


Dr. Lindsay RosenwaldPhoto Credit: Biotechnology-Info


Dr. Lindsay RosenwaldPhoto Credit: FemaleCare.net


By taking in consideration the highest moral values, Dr. Lindsay Rosenwald and his colleagues aim to deliver with integrity.


In order for the company to reach success, it has set the following objectives:
• To invest in life sciences and biotechnology, and to minimize risk and maximize returns
• To finance and support emerging and mid-cap publicly-traded biotech companies that may lack financial and industry support
• To collaborate with industry participants (buy-side, sell-side, venture capitalist, pharma, and biotech) to create a team approach to assisting emerging companies so the company can better achieve its goals.


With Dr. Rosenwald as leader of the company, OpusPoint Partners holds a promising future.


More information on Dr. Lindsay Rosenwald is available at DrLindsayRosenwald.com.

Huwebes, Agosto 11, 2011

Lindsay Rosenwald: A bright future for life science and healthcare

Creative thinkers alike, Lindsay Rosenwald and Michael S. Weiss created OpusPoint Partners. The company’s commitment, as stated in their website, is to identify and invest innovations in life science and healthcare that will change the way diseases are diagnosed, the way patients are cared for and the way healthcare and medicine are delivered to patients.


From Lindsay RosenwaldBiotechnology-info Blogspot


With a two-fold objective - first, to achieve long term goals while producing short term gains, and second, to build solid relationships in both world of investing and biotechnology -OpusPoint Partners aims to build a better future for life science and healthcare.


Working with clean intentions, OpusPoint Partners intends to reach its goal of improving the life and health of people by performing proper and ethical methods in clinical procedures and trials. It also aims to raise the bar in biotechnology investment by maximizing the returns for the investors, which will be possible if practices of moral business principles are followed.


From Lindsay RosenwaldThe Gemini Geek


Lindsay Rosenwald’s and Michael S. Weiss’ expertise in the field of medicine and investments contributes in making the vision of OpusPoint Partners a reality.


From Lindsay RosenwaldLindsay Rosenwald Blogspot



OpusPoint Partners’ mission is not an easy task. Lindsay Rosenwald knows that in order to meet projected goals, which OpusPoint Partners has been already been doing, it’s important to exert a lot of effort, time and money. And with Lindsay Rosenwald’s support, with all his success in biotechnology ventures, OpusPoint Partners is on its way to achieving its goals on providing a brighter future for people.


To know more about Lindsay Rosenwald, go to www.lindsayrosenwald.org.